Raymond James Financial Inc. Invests $887,000 in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Raymond James Financial Inc. acquired a new stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 51,237 shares of the real estate investment trust’s stock, valued at approximately $887,000.

A number of other large investors have also bought and sold shares of SBRA. Geode Capital Management LLC boosted its holdings in shares of Sabra Health Care REIT by 1.7% in the third quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after buying an additional 104,533 shares during the period. JPMorgan Chase & Co. increased its holdings in Sabra Health Care REIT by 222.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock worth $183,996,000 after purchasing an additional 6,819,919 shares in the last quarter. Vestcor Inc raised its stake in shares of Sabra Health Care REIT by 62.5% in the 3rd quarter. Vestcor Inc now owns 207,918 shares of the real estate investment trust’s stock valued at $3,869,000 after purchasing an additional 79,956 shares during the period. Barclays PLC lifted its holdings in shares of Sabra Health Care REIT by 56.1% in the third quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust’s stock valued at $12,624,000 after purchasing an additional 243,895 shares in the last quarter. Finally, Franklin Resources Inc. boosted its position in shares of Sabra Health Care REIT by 12.3% during the third quarter. Franklin Resources Inc. now owns 524,917 shares of the real estate investment trust’s stock worth $9,543,000 after buying an additional 57,551 shares during the period. 99.40% of the stock is owned by institutional investors.

Sabra Health Care REIT Price Performance

Shares of SBRA opened at $17.28 on Friday. The company has a market cap of $4.11 billion, a price-to-earnings ratio of 32.60, a PEG ratio of 1.97 and a beta of 0.93. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The company’s fifty day simple moving average is $16.89 and its 200 day simple moving average is $17.65. Sabra Health Care REIT, Inc. has a 1-year low of $13.31 and a 1-year high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The company had revenue of $182.35 million for the quarter, compared to analysts’ expectations of $178.01 million. On average, research analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.94%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 226.42%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Truist Financial boosted their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Tuesday, March 18th. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research report on Tuesday, January 7th. Finally, Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Sabra Health Care REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.33.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.